Market Overview
The Neurorehabilitation
Devices Market Size exhibiting
a compound annual growth rate (CAGR) of 7.90% during the forecast period (2023
- 2032). Neurological rehabilitation is a treatment program overseen by a team
of specialists for patients suffering from sickness, injury, or malfunction of the
neurological system. Neurorehabilitation devices are used in the field of
physiotherapy to aid in the learning of motor abilities. Neurorobotic systems,
non-invasive brain stimulators, brain-computer interfaces, and wearable devices
are all examples of neurorehabilitation equipment. With the use of these
technologies, rehabilitation products have advanced and improved in terms of
intensity and quality. It has ensured that neurorehabilitation equipment
provides the best and most important results in neurological illnesses.
Competitive Landscape
The
Neurorehabilitation Devices Market players in the market are :
Abbott Laboratories,
Ekso Bionics Holdings Inc,
Helius Medical Technologies,
Hocoma AG,
Medtronic Inc,
Others
Following
the pandemic, a developing culture of entrepreneurs, and neuroscientists, the
Neurorehabilitation Devices Market is now open to a variety of people who wish
to make money. Those who have invested in the Neurorehabilitation Devices
Market have contributed to the advancement of this culture and market trends.
In reality, patients are now consulting remotely for each of their application
parts. As a result, it has provided a landscape for the neurorehabilitation
device industry, as well as the possibility to interact with diverse persons to
move the market forward. Parkinson's disease and stroke are the diseases with
the highest CAGR in terms of application category in the coming years.
Market Segmentation
Based
on the Type, the global Neurorehabilitation Devices Market has been segmented
into Neuro-Robotic Devices, Wearable Devices, Non-Invasive Stimulators,
Brain-Computer, and Interface (BCIs).
Based
on the Application, the global Neurorehabilitation
Devices Market has been segmented into Brain stroke, Parkinson's Disease,
Multiple sclerosis, Spinal cord injury, Cerebral palsy, Schizophrenia, etc.
Based
on the End-User, the global Neurorehabilitation Devices Market has been
segmented into Hospitals/Clinics and Cognitive Care Centers.
Based
on the Region, the global Neurorehabilitation Devices Market has been segmented
into North America, Europe, Asia Pacific, Latin America, and the Middle East
& Africa.
Regional Classification
North
America dominates the worldwide market with the United States and Canada. The
regional market has grown as the occurrences of Alzheimer's and Parkinson's
disease has increased, leading to an increase in government financing through
particular Senate of Canada programs. Europe consists of the UK, Germany,
Italy, France, Belgium, Russia, Poland, and the rest of Europe. The
Asia-Pacific includes India, Australia, New Zealand, China, South Korea, Japan,
Thailand, Indonesia, and Vietnam, as well as the rest of the continent. The
market for neurorehabilitation equipment is predicted to expand gradually. The
architecture of medicine is changing, and it is expected that healthcare
infrastructure and neurological devices will develop during the forecast period.
According to statistics, market growth in areas where the majority of the
population is over 60 years old ranges from 8.1 percent to 8.5 percent every
year.
Related reports-
About US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New
York 10013
